HCA Healthcare Inc (NYSE: HCA) has a higher price-to-earnings ratio of 18.14x compared to its average ratio. HCA has 36-month beta value of 1.67. Analysts have mixed views on the stock, with 10 analysts rating it as a “buy,” 6 as “overweight,” 6 as “hold,” and 0 as “sell.”
The public float for HCA is 185.65M, and currently, short sellers hold a 1.43% ratio of that float. The average trading volume of HCA on September 11, 2024 was 1.22M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
HCA) stock’s latest price update
The stock of HCA Healthcare Inc (NYSE: HCA) has increased by 0.06 when compared to last closing price of 386.43. Despite this, the company has experienced a -1.94% fall in its stock price over the last five trading sessions. zacks.com reported 2024-09-09 that The U.S. economy added 142, 000 jobs in August 2024, more than a downwardly revised 89, 000 in July but below forecasts of 160, 000.
HCA’s Market Performance
HCA Healthcare Inc (HCA) has seen a -1.94% fall in stock performance for the week, with a 6.99% gain in the past month and a 14.97% surge in the past quarter. The volatility ratio for the week is 2.25%, and the volatility levels for the past 30 days are at 1.52% for HCA. The simple moving average for the past 20 days is 0.58% for HCA’s stock, with a 21.35% simple moving average for the past 200 days.
Analysts’ Opinion of HCA
Many brokerage firms have already submitted their reports for HCA stocks, with Morgan Stanley repeating the rating for HCA by listing it as a “Equal-Weight.” The predicted price for HCA in the upcoming period, according to Morgan Stanley is $427 based on the research report published on September 03, 2024 of the current year 2024.
Robert W. Baird, on the other hand, stated in their research note that they expect to see HCA reach a price target of $396. The rating they have provided for HCA stocks is “Outperform” according to the report published on May 30th, 2024.
Barclays gave a rating of “Overweight” to HCA, setting the target price at $356 in the report published on March 06th of the current year.
HCA Trading at 8.48% from the 50-Day Moving Average
After a stumble in the market that brought HCA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -4.07% of loss for the given period.
Volatility was left at 1.52%, however, over the last 30 days, the volatility rate increased by 2.25%, as shares surge +4.67% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +22.52% upper at present.
During the last 5 trading sessions, HCA fell by -2.08%, which changed the moving average for the period of 200-days by +52.59% in comparison to the 20-day moving average, which settled at $385.29. In addition, HCA Healthcare Inc saw 42.84% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at HCA starting from Whalen Kathleen M, who sale 2,987 shares at the price of $363.51 back on Jul 31 ’24. After this action, Whalen Kathleen M now owns 9,454 shares of HCA Healthcare Inc, valued at $1,085,804 using the latest closing price.
Whalen Kathleen M, the SVP & Chief Ethics Officer of HCA Healthcare Inc, sale 1,864 shares at $359.92 during a trade that took place back on Jul 29 ’24, which means that Whalen Kathleen M is holding 12,441 shares at $670,891 based on the most recent closing price.
Stock Fundamentals for HCA
Current profitability levels for the company are sitting at:
- 0.15 for the present operating margin
- 0.49 for the gross margin
The net margin for HCA Healthcare Inc stands at 0.08. The total capital return value is set at 0.24.
Based on HCA Healthcare Inc (HCA), the company’s capital structure generated 1.04 points at debt to capital in total, while cash flow to debt ratio is standing at 0.23. The debt to equity ratio resting at -25.55. The interest coverage ratio of the stock is 5.12.
Currently, EBITDA for the company is 12.73 billion with net debt to EBITDA at 3.13. When we switch over and look at the enterprise to sales, we see a ratio of 2.08. The receivables turnover for the company is 6.68for trailing twelve months and the total asset turnover is 1.19. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.06.
Conclusion
To put it simply, HCA Healthcare Inc (HCA) has had a better performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
